Searched for
GENERIC OXALIPLATIN PRODUCTS
Torrent, Dr Reddy’s, Aurobindo, Cipla, Lupin in race to buy SagentValuation is expected to be upwards of $500 million (Rs 3,400 crore), for which large generic drug makers and financial investors like glob...- Strides Arcolab gets FDA approval for Oxaliplatin injectionOnco Therapies Ltd, a wholly owned subsidiary of Strides Arcolab today announced that it has received final ANDA approval for Oxaliplatin i...
- US court rules against Sun Pharma over cancer drugFrench drugmaker Sanofi today said a US court has ruled in its favour in a patent litigation against Sun Pharmaceuticals over Eloxatin.
- Sun Pharma Q1 net zooms 244 pc to Rs 564.32 crSun Pharmaceutical Industries today reported a 244.43 per cent jump in net profit at Rs 564.32 crore for the quarter ended June.
- Sun Pharma suffers second setback in US patent rowSun Pharmaceutical Industries suffered its second setback in the US litigation within four days after a New Jersey district court decided t...
- US court bans Sun from selling Eloxatin: Sanofi AventisFrench drug maker Sanofi Aventis SA on Friday said a New Jersey US district court ordered Sun Pharma to stop selling its generic version of...
- Sun's EPS may take a knock if it stops cancer drug saleThe stock of Sun Pharma fell for a fourth day in a row, as investors are worried about the company's legal tussle with Sanofi-Aventis over ...
- Sanofi to eclipse Sun’s Eloxatin planFrance’s largest pharma company, Sanofi-Aventis, is suing India’s Sun Pharmaceuticals and Hospira’s Mayne Pharma to prevent the latter from...
- US firm files suit against Dabur PharmaUS-based Sanofi-Aventis LLC has filed a lawsuit against Dabur Pharma and its UK arm - Dabur Oncology Pte, over a USFDA filing seeking appro...
Load More- Sun Pharma Q1 net zooms 244 pc to Rs 564.32 cr
